Clinical & Experimental Cardiology
Open Access

Masahiko Kurabayashi

Publications

• Research Article
  Real-World Data of Adaptive Servo-Ventilation Therapy for Patients with Heart Failure with Reduced Ejection Fraction: Three-Year Follow-Up Data Based on Comparison with Standard Medical Therapy
  Author(s): Keita Goto, Noriaki Takama, Yukie Sano, and Masahiko Kurabayashi Keita Goto, Noriaki Takama, Yukie Sano, and Masahiko Kurabayashi
  
  Background: Sleep-disordered breathing (SDB) is a cause of heart failure. Adaptive servo-ventilation (ASV) is one of the treatments for SDB. Recently, ASV has been applied to the treatment of patients with heart failure and SDB. The aim of this study was to estimate whether ASV therapy is effective and safe for patients with heart failure with reduced ejection fraction (HFrEF) compared with standard medical therapy in the real world, using three-year follow-up data. Methods: The patients with HFrEF (n=186) were treated with standard medical therapy plus ASV therapy (ASV group; n=57) or standard medical therapy alone (control group; n=129). We followed up the patients for 3 years. Results: The ASV group had significantly lower baseline left ventricular ejection fraction than the control group (27.9 ± 8.6% vs... View More»
  DOI: 10.4172/2155-9880.1000586

  Abstract PDF

Relevant Topics